Welcome to the 9th International Congress of the SSPH

Since the last International Congress on Pulmonary Hypertension (PH) organized by the Swiss Society for PH, many aspects in the field have evolved. The 2022 Guidelines have now entered clinical practice, novel therapies for pulmonary arterial hypertension have become available, and new data on the use of conventional therapies in daily practice have been published.

Numerous insights have also emerged in the areas of PH diagnosis, classification, pathophysiology, comorbidities, management of CTEPH, supportive therapies and rehabilitation, exposure to hypoxia, and many more. All of these will be addressed during the 2026 Congress in Engelberg.

International experts will gather for this event, offering an excellent opportunity for thoughtful discussions and scientific exchange.

We are very much looking forward to welcoming you to Engelberg for our 2026 Congress.

On behalf of the SGPH-boards

Silvia Ulrich and Benoit Lechartier